Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.460
-0.080 (-2.26%)
At close: Mar 6, 2026, 4:00 PM EST
3.451
-0.010 (-0.27%)
After-hours: Mar 6, 2026, 7:56 PM EST
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.83 billion as of March 6, 2026. Its market cap has decreased by -55.23% in one year.
Market Cap
1.83B
Enterprise Value
1.16B
1-Year Change
-55.23%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.83B, a decrease of -63.99%. That is a compound annual growth rate of -18.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.83B | -14.14% |
| Dec 31, 2025 | 2.13B | -20.16% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 1.95B |
| Aurinia Pharmaceuticals | 1.90B |
| Tyra Biosciences | 1.89B |
| Veradermics | 1.81B |
| Palvella Therapeutics | 1.81B |
| Zymeworks | 1.78B |
| Relay Therapeutics | 1.77B |
| Definium Therapeutics | 1.76B |